Subtype-specific transcription factors are clinically relevant and show distinct therapeutic vulnerabilities in human small cell lung cancer

Authors :: C Lang
Z Megyesfalvi
B Szeitz
A Lantos
N Woldmar
Z Valko
A Schwendenwein
F Oberndorfer
N Barany
S Paku
V Laszlo
H Kiss
E Bugyik
B Ferencz
K Dezso
Z Lohinai
J Moldvay
J Fillinger
G Galffy
C Rivard
F R Hirsch
L Brcic
H Popper
I Kern
M Kovacevic
J Skarda
M Mittak
A M Szasz
L Pizzatti
K Bogos
M A Hoda
K Hoetzenecker
G Marko-Varga
P Horvatovics
F Renyi-Vamos
T Klikovits
K Schelch
M Rezeli
B Döme
Source :: 11.01 - Lung cancer.
Publication Year :: 2022
Publisher :: European Respiratory Society, 2022.

Full Text Access

Tools